News

blood testing, nephrocheck

The U.S. Food and Drug Administration has allowed marketing of the NephroCheck test, a first-of-a-kind laboratory test to help determine if certain critically ill hospitalized patients are at risk...

September 29, 2014 — AliveCor announced the launch of the latest version of the AliveECG app, which provides patients with free real-time atrial fibrillation (AF) detection in electrocardiogram (...

September 26, 2014 — Biotronik announced that the results of the EDUCAT study support a link between patient comprehension and clinical acceptance regarding remote monitoring. The study...

September 24, 2014 — An initiative to improve the use of cardiac telemetry at Christiana Care Health System enhanced the value of care to patients and resulted in savings of $4.8 million,...

A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes to the current standard of care. The...

Unexpected trips to the hospital are inconvenient and worrisome for anyone, but for congestive heart failure sufferers, they can be all too frequent.

September 16, 2014 — A quarter of adults in the United States have two or more chronic medical conditions, as do more than two-thirds of seniors, yet there are few clinical practice guidelines for...

PressureWire St. Jude Medical Two-year FAME 2 Data FFR-guided PCI

St. Jude Medical Inc. announced primary outcome two-year data from the FAME 2 Trial, which demonstrated sustained superiority with FFR-guided PCI using St. Jude Medical PressureWire technology in...

September 12, 2014 — Volcano Corp. announced it will be launching its interventional precision guidance tools at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific...

Geneia announced a multi-year, strategic partnership with Covidien to help improve the health of and reduce the costs for chronically ill patients. 

September 10, 2014 — ResMed announced results from a study presented at the 2014 European Society of Cardiology (ESC) Congress in Barcelona, Spain, looking at the use of the at-home, contactless,...

September 4, 2014 — St. Jude Medical announced a new multicenter clinical trial has found that using the company’s fractional flow reserve (FFR) technology changed the course of...

DNA, sudden cardiac death

A research study published in the July issue Journal of the American College of Cardiology reports that genetic mutations in a neuronal sodium channel gene are associated with...

The mantra for treatment for high blood pressure has been "the lower, the better," but that goal can potentially put patients at risk of kidney failure or death, according to a Kaiser Permanente...

August 22, 2014 — AliveCor announced the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial fibrillation (AF), the most common form of...

August 21, 2014 — diaDexus announced it has received notice from the U.S. Food and Drug Administration (FDA) that an administrative acceptance review was conducted on the traditional 510(k)...

August 21, 2014 — Efforts over the past decade to improve the quality of care for cardiovascular disease patients and increase the use of evidence-based treatments have led to a significant drop...

Boston Scientific Corp. and Asahi Intecc have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. 

August 15, 2014 — Zoll Medical Corp. announced its Japanese subsidiary, Asahi Kasei Zoll Medical (AZM), has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare to...

SunTech Centron Diagnostics Central Blood Pressure Technology

SunTech Medical acquired King’s College London’s central blood pressure technology as well as the assets of Centron Diagnostics Ltd., including the clinically-validated cBP301 Central Blood...